Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling Pathway
Xiaozhong Liao(Southern Medical University), Lingling Sun(Second Affiliated Hospital of Zhejiang University), Zhe‐Sheng Chen(New York College of Traditional Chinese Medicine), Haiyan Du(Guangzhou University of Chinese Medicine), Hanrui Chen(Guangzhou University of Chinese Medicine), Zhuo‐Xun Wu(St. John's University), Jing Wang(Lishui Central Hospital), Lizhu Lin(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Wei Guo(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Jue Zhang(Inner Mongolia Normal University), Lan-Ting Tao(First Affiliated Hospital of Guangzhou University of Chinese Medicine)
Cited by 19
Related Papers
Microbiota in health and diseases
|Signal Transduction and Targeted Therapy|2022|2.9k
Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
|Cancer Research|2008|385
Assessment of the Physicochemical Properties and Biological Effects of Water Activated by Non‐thermal Plasma Above and Beneath the Water Surface
|Plasma Processes and Polymers|2014|261
Panax ginseng and its ginsenosides: potential candidates for the prevention and treatment of chemotherapy-induced side effects
|Journal of Ginseng Research|2021|127
A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial Pathway
|Journal of Medicinal Chemistry|2017|107